Conversely, accumulating evidence showed that SCFAs act through GPR41 and GPR43 in L cells to promote peptide YY (PYY) and GLP-1 and alter satiety and energy intake, which further alleviates obesity or NAFLD indirectly (33). The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.